GPCR peer analysis
Structure Therapeutics (GPCR) against its competitors: price, today's move, 1-year return and market value side by side.
GPCR and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BIOA BioAge Labs | $5.37 | -3.01% | -26.10% | – |
| BMEA Biomea Fusion | $0.56 | -4.65% | -55.16% | – |
| KLRA Kailera Therapeutics | $13.31 | 9.37% | – | – |
| MAZE Maze Therapeutics | $34.69 | 6.64% | -10.55% | – |
| MLYS Mineralys Therapeutics | $15.33 | 0.59% | -61.77% | – |
| MTVA MetaVia | $1.09 | -18.66% | -88.72% | – |
| SEPN Septerna | $48.78 | 3.02% | 143.42% | – |
| VTVT vTv Therapeutics | $21.74 | -9.53% | 2.69% | $95.01M |
| GPCR Structure Therapeutics | $20.00 | 4.82% | -42.90% | – |
- GPCR's peers: BIOA (BioAge Labs), BMEA (Biomea Fusion), KLRA (Kailera Therapeutics), MAZE (Maze Therapeutics), MLYS (Mineralys Therapeutics), MTVA (MetaVia), SEPN (Septerna), VTVT (vTv Therapeutics).
Updated 2026-11-07 11:54 UTC